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Background: Hyperemesis gravidarum (HG) is characterized by severe intractable nausea and vomiting in
pregnancy leading to electrolyte imbalance, ketonuria, and weight loss. The cause is unknown. This study
sought to investigate the prevalence and characteristics of HG in the Western Galilee in two ethnic
populations and to estimate its economic burden.
Methods: Data on ethnicity, age, gestational age, number of pregnancies, and length of hospitalization were
collected from the medical files of all women with HG admitted to the Galilee Medical Center in 2010–2013.
Findings were compared between Arabs and Jews. Prevalence was assessed relative to total number of births.
Economic burden was assessed by cost of hospitalization and work days lost.
Results: The cohort included 184 women, 124 Arabic (67.4 %) and 60 Jewish (32.6 %). There were 13,630
births at the medical center during the study period, for a calculated prevalence of HG of 1.2 %. There was
no difference in the relative proportions of Arabs and Jews between the cohort and the total women giving
birth at our center. Mean patient age was 27.2 years, gestational age 9.3 weeks, parity 2.35. Mean age was
significantly higher in the Jewish group. There were no significant between-group differences in the other
clinical parameters. Mean number of hospitalization days was 2.24 days, and of additional rest days prescribed, 4.62.
The calculated annual cost of HG was 452,943.42 NIS (120,144.14 USD), crudely extrapolated to a nationwide cost of
15–20 million NIS (5,300,000 USD).
Conclusion: The prevalence and characteristics of HG are similar in the Arabic and Jewish populations of northern
Israel. Mean gestational age at admission for HG was lower in our study than earlier ones, probably owing to the
universal health care provided by law in Israel. HG prevalence was twice that reported previously in southern Israel but
still within the range observed in other world regions. The socioeconomic differences between Arabs and Jews in the
Galilee are smaller than elsewhere in Israel, suggesting a multifactorial etiology of HG. HG poses a major economic
burden which should be considered when planning health policies. Further studies of this issue are warranted.
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Approximately 50 % – 90 % of women experience nau-
sea and vomiting during pregnancy [1]. A much smaller
percentage, ranging from 0.3 % to 2.0 %, are diagnosed
with hyperemesis gravidarum (HG), a type of severe
intractable vomiting accompanied by dehydration, keto-
nuria, electrolyte disturbance, and weight loss of more
than 5 % of the prepregnancy weight [1]. HG typically
appears between 3 and 5 gestational weeks and resolves
by 20 weeks [2]. Besides its high morbidity, HG poses a
considerable economic burden in terms of hospitalization
days and loss of work days for otherwise healthy func-
tional persons [3]. The cause is unknown, although several
studies have putatively implicated high human chorionic
gonadotropin levels [4], hyperthyroidism [5], and Helico-
bacter pylori infection [6]. HG has also been associated
with female fetuses [7]. However, despite the possible
metabolic component of HG, very few studies have com-
pared prevalence rates among ethnic groups, given their
known differences in food consumption and lifestyle, or
investigated the possible role of environmental factors.
Most of the ethnicity-related findings in HG were second-
ary to investigations of fetal outcome and included a sig-
nificantly high incidence in non-white populations (33 %
vs 16 % in white populations; p <0.05) [8] and east-Asian
populations (3.6 %) [9]; others noted no difference be-
tween specific ethnic groups [10, 11]. The only study of
HG that focused specifically on ethnicity, conducted in
Norway, showed that immigrants were at higher risk than
native Norwegians [12], possibly pointing to the involve-
ment of genetic factors as well.
The widely diverse population of northern Israel, espe-
cially the Galilee, includes several ethnic groups with
unique genetic makeup. The Jews and Arabs who inhabit
the region have many distinct cultural and lifestyle
habits. For instance, Arabs consume high levels of olive
oil in addition to meat, particularly lamb, and other fatty
foods compared to Jews. A higher proportion of Arab
men than Jewish men are smokers, and consequently, a
higher proportion of Arab women than Jewish women
are exposed to second-hand smoke [13]. Although the
exact rates of these parameters in Arabs and Jews and
their various subpopulations (e.g., Ashkenazi/Sephardic
Jews; Muslim/Christian Arabs, Druze), are difficult to
determine, they may at least partly explain the relatively
high prevalence of the metabolic syndrome in Israeli
Arabs [13].
To date, the only study of the incidence of HG in
Israel, overall and by ethnicity, was conducted in Soroka
Medical Center situated in the southern city of Beer
Sheva [14]. Findings were compared between the Jewish
and Bedouin populations, with the Jewish population
showing a significantly higher incidence of HG. How-
ever, the Arab populations of southern and northernIsrael differ greatly in terms of genetics, culture, and
socioeconomic factors. For example, the residents of
the city of Rahat in the south are exclusively Muslim
Bedouin. The rate of individuals with an academic
education is very low, and the average socioeconomic
grade is 1/ 10 (Rahat) [15].
By contrast, the residents of the Arab town of Mi’ilya
in the Galilee are almost exclusively Catholic. More than
30 % have an academic education and the average socio-
economic grade is 6/10 [15].
The present study was conducted in the Department
of Obstetrics and Gynecology of the Galilee Medical
Center in Nahariya, the largest such facility in northern
Israel, serving a catchment area of 570,000 residents.
More than 5000 births take place here each year, the
highest number north of Tel Aviv. The aim of the study
was to investigate the prevalence and characteristics of
HG among women living in the northern region of the
Galilee, with comparison between Jews and Arabs. We
also examined its economic burden in terms of
hospitalization costs and, as HG affects women of repro-
ductive age who are usually working, in lost work days.
We hypothesize that there is a significant difference in
the prevalence of HG between these two ethnic popula-
tions, which would suggest a multifactorial etiology,
including lifestyle habits and a possible genetic compo-
nent. Second, we hypothesize that HG constitutes a large
burden on the Israeli economy.
Methods
A retrospective population-based epidemiological study
design was used. The database of the Department of
Obstetrics and Gynecology of Galilee Medical Center,
Nahariya, Israel was reviewed for all women admitted
with a diagnosis of HG from December 1, 2010–December
31, 2013. Data on ethnicity (Jewish/Arabic), age, gesta-
tional age (in weeks) at admission, number of pregnancies
and number of hospitalization days were collected from
the medical files. Each woman admitted counted as a sin-
gle case, regardless of the number of her hospitalizations
for HG during the study period. Criteria for the diagnosis
of HG were intractable vomiting, dehydration, electrolyte
disturbance, and ketonuria. According to hospital policy,
women who present with HG are referred to the De-
partment of Obstetrics and Gynecology, so the cases
of HG included in the study represent 100 % of all
cases seen in the medical center during the study
period. The study protocol was approved by the local
Institutional Review Board (Helsinki Committee).
The data were summarized using Microsoft Excel and
processed statistically using a binominal test. To deter-
mine the prevalence of HG, the number of cases of HG
was calculated as a proportion of the total number of
births at our center during the same period, overall and
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age at admission between Jewish and Arab women. Non-
parametric Mann-Whitney test was used to compare the
groups for gestational age at admission and number of
hospitalization days. A p value of <0.05 was considered
statistically significant. The economic burden of HG (P),
we calculated the average length of hospitalization (d),
average number of additional rest days prescribed at
discharge (r), price of a single hospitalization day (c),
average employee daily wage (w) And rate of unemploy-
ment (e). These parameters were used to build the
following equation: p = e*(d + r)*w + (d*c).
According to Israeli law, the state is responsible for
providing health services, including hospitalization, to all
residents of the country, who may register with any one
of the four health maintenance organizations (HMOs).
The cost of hospitalization in public hospitals is deter-
mined by the Israel Ministry of Health and paid by the
HMOs, who submit an annual report to the ministry.
The average wage in the Galilee for women and the un-
employment rate during the study period were derived
from the most recent (2011) published data of the Israel
Central Bureau of Statistics.
Results
The cohort included 184 women with HG, 124 Arabic
(67.4 %) and 60 Jewish (32.6 %). There were 13,630
births at the medical center during the study period, for
a calculated prevalence of HG of 1.2 %. There was no
significant difference in the relative proportions of
Arabic and Jewish women between the study group and
the total population of women who gave birth during
the study period (Arabic: n = 8586, 63 %; Jewish: n =
5043, 37 %; 0.189).
The demographic data of the patients are summarized
in Table 1. Mean (±2SD) values for the cohort were age
27.2 years (range 16–44), gestational age 9.2 weeks
(range 5–17.5), and number of pregnancies 2.35 (range
1–4). On analysis by ethnicity, the Jewish group was sig-
nificantly older than the Arabic group (28.9 ± 10.6 years
vs 26.4 ± 10.2 years, p = 0.002). There were no significant
differences between the Arabic and Jewish groups in
mean (±2SD) gestational age (9.3 ± 4.8 weeks vs 9.2 ±
5.8 weeks, p = 0.478) or number of pregnancies (2.2 ± 2.8
vs 2.5 ± 4.2, p = 0.298). The mean (±2SD) number ofTable 1 Background parameters of 184 women hospitalized for HG
Parameter Total cohort
No. patients (%) 184
Age (yr), mean ± 2SD (range) 27.3 ± 10.6 (16-44)
Gestational age (wk), mean ± 2SD (range) 9.28 ± 5.2 (5-17.5)
No. of pregnancies, mean ± 2SD (range) 2.35 ± 3.4 (1-4)
Length of hospitalization (days), mean ± 2SD (range) 2.24 ± 2.6 (1-9)hospitalization days was 2.2 ± 2.2 in the Arabic group
and 2.2 ± 3.4 in the Jewish group with a smaller range of
hospitalization days for Arab women (p = 0.034).
Analysis of the economic burden showed that HG
accounted for an annual average of 137.6 hospitalization
days. The average number of rest days prescribed per
patient was 4.62, for an annual average of 283.36. The
price of one day’s hospitalization day in the Department
of Obstetrics and Gynecology during the study period
was 2999 NIS [16]. According to the most recent (2011)
estimate, the average daily wage for women in the region
was 292.74 NIS [17], and the estimated employment rate
for women in the Galilee was 55.2 % [18]. Therefore,
using our equation, the estimated cost of HG in the
Western Galilee of Israel during the study period was
452,943.42 NIS (120,144.14 USD, 3.77 NIS/1 USD).
Hospitalization accounted for the bulk of this amount
(412,662.4 NIS), paid by the health service funds, and
lost work days for the remainder (40,281.02 NIS), paid
by employers (given that employers often arrange for
substitutes for absentee employees at the same daily
wage). Considering that the total annual number of births
in Israel is much higher than in the Western Galilee alone,
reaching 170,940 in 2013 [19], the estimated national an-
nual cost of HG may reach more than 15 million NIS.
Moreover, the unemployment rate in the Western Galilee
is significantly higher than central Israel [20], and the
average daily wage is significantly lower [20]. If we adjust
the figures to central Israel, taking higher employer losses
and additional expenses (such as spouses taking work
leave to attend to children at home) into account, the
figure may easily rise to 15–20 million NIS per year
(5,300,000 USD).
Discussion
The present study describes the characteristics of HG in
the Western Galilee region of Israel, its possible associ-
ation with ethnicity (Arabic/Jewish), and its economic
impact. The possible connection of HG to ethnicity has
hardly been investigated. The major studies conducted
to date are shown in Table 2. Our search of the medical
literature yielded no studies on the role of environmen-
tal factors in HG.
The main finding of the present study is that HG has
a prevalence rate of 1.2 % in the Western Galilee. This is, total and by ethnicity
Arabs Jews P value (Arabs vs Jews)
124 (67.4 %) 60 (32.6 %)
26.4 ± 10.2 (16-40) 28.9 ± 10.6 (16-44) 0.002 (t-test)
9.3 ± 4.8 (5-17) 9.2 ± 5.8 (5.5-17.5) 0.478 (Mann-Whitney)
2.2 ± 2.8 (1-4) 2.5 ± 4.2 (1-4) 0.298 (chi-square)
2.2 ± 2.2 (1-6) 2.2 ± 3.4 (1-9) 0.034 (Mann-Whitney)
Table 2 Summary of studies evaluating the connection between HG and ethnicity
Study Study population Ethnicity in aim of study Ethnic groups assessed HG prevalence
Vilming and Neshem [10], Norway
(1993-1997)
N = 120 Primary Norwegian, non-Norwegian Higher in
non-Norwegian
Paauw et al [20], USA (1984-1991) N = 45 Secondary Whites, non-White Higher incidence
in non-Whites
Vlachodimitropoulou-Koumoutsea
et al [9], UK (2007-2010)




Bailit [2], USA (1999) N = 2,466 Secondary White, Non-White, Hispanic Higher in
Non-Whites
Bashiri et al [4], Israel (19985-1988) N = 164 Secondary Jewish, Bedouin Higher in Jewish
Konikoff et al. Israel (2010-2013) N = 184 Primary Jewish, Arab No significant
difference
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Israel (0.6 %) but still within the accepted range of the
proportion of pregnancies complicated by HG (0.3–2 %)
[2] and similar to other regions in the world [1, 2].
Our analysis showed that Jewish women with HG are
significantly older than Arabic women with HG. This
finding was not unexpected given the general cultural
differences between the populations [21]. Whether pa-
tient age affects the incidence of HG is unclear. Others
have shown that HG is more prevalent in younger
women [1].
The average gestational age at admission for HG
(9.2 weeks). is considerably lower than the average re-
ported by a large epidemiologic study on HG from
California (11.3 gestational weeks) [2]. The difference
may be explained by the mandatory medical coverage
of all residents in Israel as opposed to the largely pri-
vate healthcare system in the United States, which
makes patient referral for hospitalization considerably
easier in Israel.
The average length of hospitalization for HG in our
study (2.24 days) is similar to findings in the study from
California (2.6 days) [2].
The relative proportions of Jewish and Arabic women
hospitalized for HG in our cohort reflect the ethnic
composition of the population of the Western Galilee.
The lack of a significant difference between the Arab
and Jewish groups in the proportion of HG cases out of
total births does not agree with our hypothesis. We find
it surprising given the distinct genetics and lifestyles of
the two groups as well as the higher incidence of HG in
Jewish than in Bedouin women reported by Bashiri et al
[14] in southern Israel. These authors suggested that the
poorer and less educated Bedouin women may not have
presented for treatment because of a lower awareness of
the serious complications of HG than the Jewish women.
Alternatively, they may have a true low prevalence for
unknown reasons. In the Western Galilee, the Arab
population has a lower socioeconomic status than the
Jewish population, but it is still higher than that of thesouthern Bedouin. Accordingly, in our study, there was
no between-group difference in parity. Furthermore,
although the Arab population of the Western Galilee is
mainly Muslim and has a high rate of consanguineous
marriage whereas the Jewish population is made up
mainly of individuals of European descent or new immi-
grants from the former Soviet Union, the proportion of
Jews of Middle Eastern and north African descent is
steadily growing. This may have increased the genetic
and lifestyle similarity of the Jewish and Arab groups.
Owing to the retrospective nature of this study, we were
unable to determine the exact proportion of Jews of
European, Middle Eastern, and North African descent.
These factors require additional in-depth investigations.
The present study highlights the economic burden of
HG in Israel, reaching almost half a million shekels an-
nually in the Western Galilee alone. Most of the cost is
carried by the HMOs. The crudely estimated cost for
the entire country, taking into account the denser popu-
lation, higher employment rate, and higher average salar-
ies in central Israel, is15–20 million shekels (5,300,000
USD). Thus, HG must be considered in health services
planning.
This study is limited by its retrospective design.
Additionally, the assessment of national trends based
on regional studies in Israel is difficult owing to the
wide diversity of the populations in terms of cultural
background, lifestyle habits, socioeconomic status,
educational level, and quality of medical care. Studies
are needed comparing HG between the central and
peripheral areas of the country and among the various
subpopulations.
Conclusions
The overall prevalence of HG in the Western Galilee is
1.2 %, similar to reports in other regions and countries.
The similar prevalence rates of HG in the region’s Arabic
and Jewish populations, which have widely diverse
national, cultural, and lifestyle backgrounds, may suggest
a multifactorial etiology. HG exerts a considerable
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also on the financial system, as it affects young women
who make up a considerable proportion of the working
public. This issue, which has never been addressed, has
major implications for increasing the number and quality
of ambulatory community clinics in the area, especially in
the poorer sectors, and raising awareness of the syndrome
and the importance of its early management among both
the public and medical professionals. Many question re-
main unresolved, and further investigations are warranted.
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